We are live on ! Find out more
WBC

Westpac Banking Corp Portfolio holdings

AUM $1.44B
1-Year Est. Return 28.5%
This Fund
S&P 500
This Quarter Est. Return
+2.12%
1 Year Est. Return
+28.5%
3 Year Est. Return
+98.33%
5 Year Est. Return
+127.17%
10 Year Est. Return
+490.99%
AUM
$10.3B
AUM Growth
-$119M
Cap. Flow
-$230M
Cap. Flow %
-2.24%
Top 10 Hldgs %
22.86%
Holding
963
New
75
Increased
300
Reduced
309
Closed
35

Sector Composition

Rank Sector Weight
1 Healthcare 22.46%
2 Technology 18.36%
3 Financials 10.82%
4 Communication Services 8.93%
5 Real Estate 7.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LYB icon
1
LyondellBasell Industries
LYB
$19.5B
$270M 2.64%
2,488,901
-91,186
-4% -$9.86M
MNK
2
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$268M 2.62%
+2,977,965
New +$233M
AGN
3
DELISTED
Allergan plc
AGN
$256M 2.5%
1,061,041
+11,050
+1% +$2.47M
ENDP
4
DELISTED
Endo International plc
ENDP
$238M 2.32%
3,489,333
+313,554
+10% +$20.7M
AVGO icon
5
Broadcom
AVGO
$1.82T
$235M 2.29%
27,041,300
-3,213,520
-11% -$25.1M
GOOG icon
6
Alphabet (Google) Class C
GOOG
$3.9T
$226M 2.2%
7,806,715
-64,476
-0.8% -$1.86M
NXPI icon
7
NXP Semiconductors
NXPI
$68B
$226M 2.2%
3,296,117
-109,590
-3% -$7.29M
JAZZ icon
8
Jazz Pharmaceuticals
JAZZ
$15.9B
$224M 2.18%
1,392,130
-143,729
-9% -$22.1M
CHKP icon
9
Check Point Software Technologies
CHKP
$13.3B
$223M 2.17%
3,222,164
-151,661
-4% -$10.3M
GILD icon
10
Gilead Sciences
GILD
$161B
$179M 1.74%
1,680,511
+13,631
+0.8% +$1.33M
BIIB icon
11
Biogen
BIIB
$29.9B
$171M 1.67%
518,235
+422,317
+440% +$139M
ORCL icon
12
Oracle
ORCL
$331B
$149M 1.45%
3,887,015
+193,606
+5% +$7.84M
AAPL icon
13
Apple
AAPL
$4.89T
$139M 1.36%
5,523,548
-75,428
-1% -$1.85M
BHC icon
14
Bausch Health
BHC
$1.65B
$136M 1.33%
1,037,809
+76,248
+8% +$9.09M
VLO icon
15
Valero Energy
VLO
$89.8B
$133M 1.3%
2,879,666
+693,201
+32% +$35M
MU icon
16
Micron Technology
MU
$1.04T
$123M 1.2%
3,583,120
+93,598
+3% +$3.03M
TFCFA
17
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$115M 1.12%
3,364,397
+162,715
+5% +$5.63M
SWK icon
18
Stanley Black & Decker
SWK
$14.2B
$114M 1.11%
1,287,687
+47,376
+4% +$4.24M
KKR icon
19
KKR & Co
KKR
$89.2B
$113M 1.1%
5,053,931
+494,497
+11% +$11.6M
BX icon
20
Blackstone
BX
$104B
$110M 1.07%
3,568,022
+187,593
+6% +$6.1M
WLK icon
21
Westlake Corp
WLK
$9.46B
$107M 1.04%
1,236,823
-158,998
-11% -$14.4M
SPG icon
22
Simon Property Group
SPG
$74.5B
$106M 1.03%
641,980
-129,956
-17% -$21.9M
MSFT icon
23
Microsoft
MSFT
$2.84T
$88.3M 0.86%
1,904,058
+24,839
+1% +$1.11M
JNJ icon
24
Johnson & Johnson
JNJ
$634B
$86.5M 0.84%
811,585
+37,228
+5% +$3.86M
JPM icon
25
JPMorgan Chase
JPM
$939B
$84.3M 0.82%
1,400,062
-8,789
-0.6% -$514K

Similar funds

Westpac Banking Corp's Q3 2014 Portfolio in Review

As of Q3 2014, Westpac Banking Corp held 963 positions worth $10.3B, down 1.1% from $10.4B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Westpac Banking Corp's Q3 2014 filing shows 75 new, 300 increased, 309 reduced and 35 closed positions. Its largest new stake was MALLINCKRODT PUBLIC LIMITED COMPANY: 2,977,965 shares worth $268M. The largest sale was Chicago Bridge & Iron Nv, an estimated $159M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 18% a quarter earlier, followed by Technology and Financials.

  • Westpac Banking Corp's largest Q3 2014 buy was MALLINCKRODT PUBLIC LIMITED COMPANY: 2,977,965 shares worth $268M.
  • Westpac Banking Corp added most to Biogen in Q3 2014, an estimated $139M increase.
  • Westpac Banking Corp's biggest Q3 2014 reduction was Chicago Bridge & Iron Nv, cutting an estimated $159M.
  • Westpac Banking Corp fully exited Apollo Global Management in Q3 2014, selling an estimated $113M.
  • Westpac Banking Corp's ten largest holdings make up 23% of its $10.3B portfolio in Q3 2014.
  • Westpac Banking Corp opened 75 new positions and closed 35 in Q3 2014.
  • Westpac Banking Corp's portfolio value fell 1.1% quarter-over-quarter to $10.3B.

Based on Westpac Banking Corp's 13F filing for Q3 2014, filed 12 Nov 2014.